Zoplar Secures $3.4 Million in Series A Funding
Zoplar, a dedicated platform aimed at improving the procurement process for medical equipment in small and medium-sized hospitals, has successfully raised $3.4 million in a Series A funding round spearheaded by Blume Ventures. This funding round also witnessed contributions from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX.
To date, the company has accumulated $5.1 million in total funding, with investments from Titan Capital, Stride Ventures, and Panthera Peak.
The funds will be deployed to enhance its operational capabilities with a focus on:
- Backward integration in the supply chain
- Establishing a robust service engineering team
According to a press release from Zoplar, the company strives to make these improvements a priority.
About Zoplar
Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar develops a comprehensive medical equipment platform aimed at resolving key challenges faced by MSME hospitals. These challenges include:
- The difficulty of identifying cost-effective products
- Management of multiple vendor relationships
- Ensuring high-quality after-sales service
- Accessing financing solutions
Since launching, Zoplar asserts that it has gained considerable traction in the market. The platform has partnered with approximately 300 hospitals, including notable nephrology networks such as DCDC.
The Gurugram-based company reports an impressive 40% rate of repeat customers, highlighting the strong demand for quality medical equipment within the industry.
